Federal Cannabis Rescheduling Momentum, Cannabis Federal Rescheduling Update, Cannabis Regulatory Momentum 2026, Cannabis Rescheduling Market Impact, Cannabis Research Accessibility Changes

Tilray Surges 10%: Rescheduling Momentum Builds as Traders Await Confirmation

By Benjamin Caplan, MD

Comments Off on Tilray Surges 10%: Rescheduling Momentum Builds as Traders Await Confirmation

April 23, 2026

4 Min Read

Federal cannabis rescheduling momentum is driving significant changes in the cannabis industry and clinical research landscape. This momentum is reflected in market movements such as Tilray's recent surge. Clinicians should monitor these developments as…